Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

SELL
$82.27 - $103.29 $4,113 - $5,164
-50 Reduced 78.13%
14 $1.45 Million
Q1 2025

Apr 29, 2025

BUY
$96.6 - $161.22 $4,733 - $7,899
49 Added 326.67%
64 $6.3 Million
Q4 2024

Jan 30, 2025

BUY
$126.42 - $152.67 $1,896 - $2,290
15 New
15 $2.25 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.29B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Sierra Ocean, LLC Portfolio

Follow Sierra Ocean, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Ocean, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Ocean, LLC with notifications on news.